|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-10-4
|
|
pubmed:abstractText |
Hepatocyte growth factor promotes cancer development through cell motility-promoting and angiogenic effects. NK4, a fragment of hepatocyte growth factor, acts as its receptor antagonist. We assessed effects of NK4 gene therapy against human hepatocellular carcinoma cells (HUH7) transplanted into mice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
688-95
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16839638-Animals,
pubmed-meshheading:16839638-Carcinoma, Hepatocellular,
pubmed-meshheading:16839638-Cell Line, Tumor,
pubmed-meshheading:16839638-Cell Movement,
pubmed-meshheading:16839638-Gene Therapy,
pubmed-meshheading:16839638-Genetic Vectors,
pubmed-meshheading:16839638-Hepatocyte Growth Factor,
pubmed-meshheading:16839638-Kaplan-Meier Estimate,
pubmed-meshheading:16839638-Liver Neoplasms,
pubmed-meshheading:16839638-Male,
pubmed-meshheading:16839638-Mice,
pubmed-meshheading:16839638-Mice, Inbred BALB C,
pubmed-meshheading:16839638-Models, Animal,
pubmed-meshheading:16839638-Neoplasms, Experimental,
pubmed-meshheading:16839638-Neovascularization, Pathologic
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
|
|
pubmed:affiliation |
First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
